Zyla Health, a health-tech startup headquartered in Gurgaon, has secured $4 million in its Series A funding round, led by Exfinity Venture Partners. Notably, Sony Innovation Fund, Venture Catalysts and Aureolis, spearheaded by Paula Mariwala, also participated in this funding initiative. The company aims to deploy the raised funds to expedite its expansion in three primary sectors: insurance, corporates, and big pharma. Moreover, Zyla Health intends to use capital infusion to integrate its products across the healthcare ecosystem to enhance scalability.

Khushboo Aggarwal, the Founder and CEO of Zyla Health, expressed enthusiasm about the company's progress, citing, "This is an incredibly thrilling phase for Zyla; we've observed a 300% year-on-year growth and maintained 100% retention of our key B2B accounts over the past year. With a strong leadership team and newfound resources to fuel our expansion, we're poised to revolutionize healthcare delivery in India". In the preceding July, Zyla Health had secured $1 million in its pre-Series A round, led by a consortium of angel investors, which included Kae Capital, Secocha Ventures, Canara Bank Ventures, and Seeders among its institutional backers.

Zyla Health operates as a care management platform, providing personalized care for chronic patients through an in-house care team. Its platform seamlessly integrates across the healthcare ecosystem using APIs, linking client data repositories, diagnostic vendors, and smart devices to enhance scalability. With an impressive clientele comprising Max Life Insurance, HDFC Ergo, Pfizer, Zydus, IBM, DHL, Godrej, GEP, among others, Zyla Health aims to ameliorate the health status of high-risk individuals, leading to reduced insurance claims, lower corporate insurance premiums, and enhanced medication outcomes for pharmaceutical users.